{"id":563503,"title":"Monitoring safety and effectiveness: Handbook for health care professionals on biosimilar biologic drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-02-16","captureTimestamp":"2026-02-16T16:02:53.615000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/monitoring-safety-effectiveness.html","snippet":"Handbook for health care professionals on biosimilar biologic drugs: Monitoring safety and effectiveness Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page The risk management plan…","rawSnapshotUrl":"/api/snapshots/raw/563503","browseUrl":"https://replay.healtharchive.ca/job-6/20260216160253/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/monitoring-safety-effectiveness.html#ha_snapshot=563503","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}